Focal angiogen therapy using intramyocardial delivery of an adenovirus vector coding for vascular endothelial growth factor 121 1 1Ronald G. Crystal and Todd K. Rosengart contributed equally as senior investigators in this study.
- 1 January 2000
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 69 (1), 14-23
- https://doi.org/10.1016/s0003-4975(99)01102-9
Abstract
No abstract availableThis publication has 24 references indexed in Scilit:
- Safety of Direct Myocardial Administration of an Adenovirus Vector Encoding Vascular Endothelial Growth Factor 121Human Gene Therapy, 1999
- Trends in Ischemic Heart Disease Deaths— United States, 1990-1994Published by American Medical Association (AMA) ,1997
- Real time quantitative PCR.Genome Research, 1996
- Angiogenesis induced by acidic fibroblast growth factor as an alternative method of revascularization for chronic myocardial ischemiaSurgery, 1996
- Effects of Vascular Endothelial Growth Factor on Hemodynamics and Cardiac PerformanceJournal of Cardiovascular Pharmacology, 1996
- Adenoviruses as Gene-Delivery VehiclesNew England Journal of Medicine, 1996
- Exercise Myocardial Perfusion SPECT in Patients Without Known Coronary Artery DiseaseCirculation, 1996
- TIMI Frame CountCirculation, 1996
- Therapeutic AngiogenesisArchives of Surgery, 1993
- Human gene therapyScience, 1992